Right ventricle dysfunction does not predict mortality in patients with SARS-CoV-2-related acute respiratory distress syndrome on extracorporeal membrane oxygenation support

Table 3 Multivariate logistic regression analysis (intensive care unit death outcome)

Model	OR	95%CI	P value
Model 1
Age (yr)	1.09	1.02-1.16	0.015
SOFA	1.26	0.99-1.62	0.062
Admission RV/LV	0.64	0.02-21.42	0.805
Model 2
SOFA	1.24	0.98-1.56	0.062
RV DYS	0.98	0.31-3.84	0.985
Creatinine (mg/dL)	1.78	0.82-3.11	0.14
Model 3
Age (yr)	1.1	1.03-1.18	0.005
BMI (kg/m2)	1.09	0.97-1.22	0.138
TAPSE (mm)	0.97	0.89-1.06	0.544
Model 4
SOFA	1.29	1.03-1.61	0.026
BMI (kg/m2)	1.06	0.95-1.19	0.278
TAPSE/SPAP (mm/mmHg)	2.53	0.03-20.92	0.68
Model 5
BMI (kg/m2)	1.1	0.98-1.24	0.107
Charlson index	0.59	0.29-1.18	0.133
Time from symptom’s onset (d)	1.26	1.02-1.56	0.032
Model 6
NT pro BNP (pg/mL)	0.99	0.97-1.02	0.517
Mechanical ventilation to ECMO ≥ 10 (d)	4.64	1.42-15.12	0.011
Creatinine (mg/dL)	2.56	1.16-5.67	0.02

BMI: Body mass index; SOFA: Symplified organ functional assessment; RV: Right ventricle; TAPSE: Tricuspid annular plane systolic excursion; sPAP: Systolic pulmonary arterial pressure; ECMO: Extracorporeal membrane oxygenation; NT-pro BNP: N terminal pro brain natriuretic peptide; OR: Odd ratio; CI: Confidence index.